ahlam1399
04-21-2016, 03:29 PM
New heart ***** struggle to win sales as doctors hold back
LONDON (Reuters) - New heart ***** hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as **vartis, which reported more weak sales for its Entresto medicine on Thursday.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=DvqFzBfsBg8:18wBXZcsKA0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DvqFzBfsBg8:18wBXZcsKA0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=DvqFzBfsBg8:18wBXZcsKA0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DvqFzBfsBg8:18wBXZcsKA0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=DvqFzBfsBg8:18wBXZcsKA0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/DvqFzBfsBg8
LONDON (Reuters) - New heart ***** hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as **vartis, which reported more weak sales for its Entresto medicine on Thursday.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=DvqFzBfsBg8:18wBXZcsKA0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DvqFzBfsBg8:18wBXZcsKA0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=DvqFzBfsBg8:18wBXZcsKA0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DvqFzBfsBg8:18wBXZcsKA0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=DvqFzBfsBg8:18wBXZcsKA0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/DvqFzBfsBg8